Form 8-K RxSight, Inc. For: May 06

Go back to Form 8-K RxSight, Inc. For: May 06

RxSight Inc. (RXST) PT Raised to $75 at Stifel

May 7, 2024 6:04 AM EDT

Stifel analyst Tom Stephan raised the price target on RxSight Inc. (NASDAQ: RXST) to $75.00 (from $68.00) while maintaining a Buy rating.

The analyst comments "RXSTs 1Q24 results confirmed (and then some) why it has been viewed as one of the best 2024 momentum stories... More

RxSight Inc. (RXST) PT Raised to $68 at Wells Fargo

May 7, 2024 5:53 AM EDT

Wells Fargo analyst Lawrence Biegelsen raised the price target on RxSight Inc. (NASDAQ: RXST) to $68.00 (from $61.00) while maintaining a Overweight rating.

The analyst comments "We raise our 2024 EPS estimate from -$1.02 to -$0.86. Our price target increases to $68 (from $61) based on 13x (from 11x... More

RxSight Inc. (RXST) PT Raised to $72 at BTIG

May 7, 2024 5:19 AM EDT

BTIG analyst Ryan Zimmerman raised the price target on RxSight Inc. (NASDAQ: RXST) to $72.00 (from $61.00) while maintaining a Buy rating.

The analyst comments "We reiterate our Buy and raise our PT to $72 PT (from $61) following 1Q24 results. RXST delivered a strong start to FY24 with 1Q24 revenue of $29.5M (69% Y/Y) and adj. LPS of $(0.25)... More